Autopsy report · NCT01221116

Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery

“The study was stopped due to difficulties in including patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 years 9 months after it had already started.
• Ran for about 5 years 11 months before it stopped.
• 23 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Ullevaal University Hospital

Sponsor type

University, hospital or other

Conditions

Heart Failure; Cardiac Surgery

Interventions

levosimendan

Participants

23

Sites

1

Countries

Norway

Trials that died the same way

• Ischemic Stroke and Early Vertical Positioning (SEVEL)
  “The required number of patients was not reached. The sites were not able to include more patients.Despite several actions the stop of the study has been decided” (80% match in meaning)
• Computed Tomography Enterography (CTE) Versus Capsule Endoscopy for Overt, Obscure Gastrointestinal (GI) Bleeding
  “The study was stopped before the first patient was enetered due to logistical issues and lack of funding.” (80% match in meaning)
• Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
  “Study stopped due to lack of efficacy.” (80% match in meaning)
• Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies
  “The study was interrupted early and terminated when only 26 out of 80 patients were enrolled due to new clinical study results indicating that the current study would not be informative.” (79% match in meaning)
• An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis
  “The study was stopped due to a non-clinical safety finding.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.